The AHA today submitted comments on the Centers for Medicare & Medicaid Services’ outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2021. The association continues its “steadfast opposition” to any payment cuts made to 340B hospitals, arguing that the Department of Health and Human Services “does not have the legal authority to punitively target 340B hospitals.”

Citing patient safety risks, AHA also strongly opposed the rule’s proposals to eliminate the inpatient-only list, remove certain restrictions on the expansion of physician-owned hospitals that qualify as high-Medicaid facilities, and change the ASC covered procedures list. The association applauded CMS’ proposed changes to the hospital overall star ratings. Read the full letter for AHA’s detailed comments on the rule.

Related News Articles

Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Blog
Public
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4…
Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…
Chairperson's File
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Headline
The Centers for Medicare & Medicaid Services Nov. 21 issued a final rule that, among other provisions, increases Medicare hospital outpatient prospective…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…